Natasha Fisher-Pearson, Martin J Lett, Isaac W D Maylam, Connor J S Philp, Mariolina Salio, Richard J Suckling, Robert Simmons, Keir Barnbrook, Benjamin Swift, Walter Jaoko, Freddie Kibengo, William Kilembe, Eduard J Sanders, Mark C Coles, Claire F Pearson, Paola Cicconi, Tomáš Hanke, Nicholas M Provine, Paul Klenerman, Jethro S Johnson
Archaea, the third domain of life, are a gut microbiome constituent, but their role in shaping immunity is poorly understood. Mucosal-associated invariant T (MAIT) cells sense microbial metabolites through their T cell receptor and contribute to antimicrobial defence and barrier homeostasis. Key sources of the major MAIT cell antigen 5-OP-RU within the human gut microbiome are unknown. Analysing microbiomes from UK, Zambian, Kenyan and Ugandan donors, we found strong correlations between archaeal riboflavin biosynthesis and circulating MAIT cell frequency and activation. Stool 5-OP-RU levels correlated with archaeal abundance. Cultures of methanogenic archaea, including the human commensal Methanobrevibacter smithii , produced 5-OP-RU and strongly activated MAIT cells without inflammation. We demonstrate a critical role for archaea in shaping human immunity, with implications for microbiome-mediated regulation of health.